Bixiye
QP60-22 MHCP Pharmacy Benefit Exclusion for Camcevi™ (leuprolide)
Taariikhda dhaqangalka Barnaamijka: Jul 13, 2022
Natiijooyinka Raadinta
Soo bandhiga 1711 - 1720 ee natiijooyinka 3688
Bixiye
P49-22 Updated Minnesota Health Care Programs and Minnesota Senior Health Options (MSHO) Prior Authorization and Medical Policy Requirements
Taariikhda barnaamijka Dhaqangalayso Agosto 01, 2022
Bixiye
2022 August Bulletins
Taariikhda barnaamijka Dhaqangalayso Agosto 01, 2022
Bixiye
P46-22 eviCore Healthcare Specialty Utilization Management (UM) Program: Medical Oncology Drug Prior Authorization Updates
Taariikhda barnaamijka Dhaqangalayso Agosto 01, 2022
Bixiye
P47-22 eviCore Healthcare Specialty Utilization Management (UM) Program: Cardiology and Radiology Clinical Guideline Updates
Taariikhda barnaamijka Dhaqangalayso Agosto 01, 2022
Bixiye
P48-22 Reimbursement Policy Update for -CO and -CQ Modifiers for Minnesota Health Care Programs
Taariikhda barnaamijka Dhaqangalayso Agosto 01, 2022
Bixiye
2022 July Bulletins
Taariikhda dhaqangalka Barnaamijka: Jul 01, 2022
Bixiye
P79R1-21 Notice of Admission (NOA) Claims Required for Home Care Claims Effective January 1, 2022
Taariikhda dhaqangalka Barnaamijka: Jul 01, 2022
Bixiye
P25R1-22 Update: Modifier -52, -CO and -CQ Reimbursement Changes – Effective July 1, 2022
Taariikhda dhaqangalka Barnaamijka: Jul 01, 2022
Bixiye
QP62-22 Commercial Pharmacy Benefit Exclusion for Propel®, Propel Mini®, Sinuva®
Taariikhda dhaqangalka Barnaamijka: Jul 27, 2022